Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    NewAmsterdam Pharma N.V.

    NASDAQ: NAMS · Real-Time Price · USD
    25.06
    -0.11 (-0.44%)
    At close: Aug 15, 2025, 3:59 PM
    24.69
    -1.48%
    After-hours: Aug 15, 2025, 06:42 PM EDT

    NewAmsterdam Pharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 771.74M 340.45M 438.52M 53.09M
    Short-Term Investments
    		 62.45M n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a 718.35K
    Other Long-Term Assets
    		 n/a 35K 146K -353
    Receivables
    		 21.3M 1.88M 2.07M 4.86M
    Inventory
    		 n/a n/a 21.5K -735
    Other Current Assets
    		 n/a n/a n/a 5.78M
    Total Current Assets
    		 863.41M 346.79M 448.13M 58.87M
    Property-Plant & Equipment
    		 673K 101K 144K 190K
    Goodwill & Intangibles
    		 534K 170K 83.16M n/a
    Total Long-Term Assets
    		 1.21M 306K 83.45M 908K
    Total Assets
    		 864.62M 347.1M 531.58M 59.78M
    Account Payables
    		 4.74M 16.92M 11.85M 7.04M
    Deferred Revenue
    		 6.01M 8.94M 13.01M 3.61M
    Short-Term Debt
    		 246K n/a n/a n/a
    Other Current Liabilities
    		 91.03M 15.96M 5.55M 519.69K
    Total Current Liabilities
    		 106.92M 49.9M 35.46M 9.88M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a 7.79M 6.75M -14.68K
    Total Long-Term Liabilities
    		 202K 8.81M 11.6M 111K
    Total Liabilities
    		 107.12M 58.7M 47.06M 9.99M
    Total Debt
    		 448K 60K 118K 164K
    Common Stock
    		 13.44M 10.17M 599.19M 83.88M
    Retained Earnings
    		 n/a -316.97M -119.36M -34.68M
    Comprehensive Income
    		 4.47M 4.42M 4.69M 591K
    Shareholders Equity
    		 757.5M 288.39M 484.52M 49.79M
    Total Investments
    		 62.45M -31.08M n/a 718.35K

    Add to Watchlist